CPAMS in Nova Scotia, Canada
- Currently over 800 Nova Scotia patients are using the service.
- 946 patients were studied in a one year pilot project funded by the Nova Scotia Ministry of Health and administered by the Pharmacy Association of Nova Scotia (PANS).
- Over 41 Nova Scotia pharmacies provide the service.
- Control is measured by assessing the time within the therapeutic range (TTR). A TTR greater than 60% is regarded as “good” control.
- The TTR for the whole CPAMS population was 71.4% and 75.7% for the most recent five months of the study.
- Patients achieved good control (TTR>60%). 72.5% of patients had a TTR>65%.
- The risk of bleeding is associated with a high INR result.
- Only 0.6% of INR results were greater than 5
- Only 0.1% of INR results were greater than 8.0
- CPAMS provides an efficient safe anticoagulant monitoring service giving a consistent high level of anticoagulant control.
See full PANS CPAMS Report